SCHEMBL330308

SCHEMBL330308

CC(=O)N[C@H](C)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL330009 1.00
SCHEMBL330011 1.00
Ammonia Solution, Strong SCHEMBL28164671 0.97 ALDH1A1 (0.48)
SCHEMBL29078950 0.97 ALDH1A1 (0.48)
SCHEMBL11433892 0.97 ALDH1A1 (0.48)
Ammonia Solution, Strong SCHEMBL28164672 0.97 ALDH1A1 (0.48)
Hydrochloric Acid SCHEMBL28235390 0.97 ALDH1A1 (0.48)
SCHEMBL29078952 0.97 ALDH1A1 (0.48)
SCHEMBL8968093 0.92 ALDH1A1 (0.45)
SCHEMBL3373326 0.90 MME (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026100273-A1 METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE NTT株式会社 2026-05-15 WO claimed
EP-4720103-A2 THERAPEUTIC USES OF ADIPOSE-SECRETED SIGNALING PROTEIN (ADISSP) University Of Massachusetts (US) 2026-04-08 EP claimed
US-12584924-B2 Compositions and methods for diagnosing and treating chronic kidney disease SOCIETE DES PRODUITS NESTLE S.A. (CH) 2026-03-24 US claimed
US-20260009800-A1 METHODS OF DIAGNOSIS AND GUIDING TREATMENT OF VULVOVAGINAL SYMPTOMS AND FEMALE SEXUAL DYSFUNCTION UNIV ARIZONA (US) 2026-01-08 US claimed
EP-3375771-B1 METHOD FOR PRODUCING LACOSAMIDE AND INTERMEDIATE THEREOF UBE CORP (JP) 2025-11-26 EP claimed
WO-2025229010-A1 COMPOSITIONS COMPRISING DALBAVANCIN HELM PHARMACEUTICALS GMBH (DE) 2025-11-06 WO claimed
WO-2025229006-A1 COMPOSITIONS COMPRISING DALBAVANCIN HELM PHARMACEUTICALS GMBH (DE) 2025-11-06 WO claimed
US-20250320265-A1 BROWN FAT-SELECTIVE ADIPOKINES UNIV MASSACHUSETTS (US) 2025-10-16 US claimed
EP-4615408-A1 VASOPRESSIN FORMULATION Hikma Pharmaceuticals USA Inc. (US) 2025-09-17 EP claimed
EP-4601615-A1 LIQUID DALBAVANCIN COMPOSITION Hikma Pharmaceuticals USA Inc. (US) 2025-08-20 EP claimed
EP-0950706-A2 D-aminoacylase DAICEL CHEMICAL INDUSTRIES, Ltd. (JP) 1999-10-20 EP claimed
US-5916774-A PRODUCES D-AMINO ACIDS FROM CORRESPONDING N-ACETYL-D-AMINO ACIDS; ACTIVITY PROMOTED BY COBALT AND CALCIUM IONS BUT INHIBITED BY COPPER, MERCURY AND ZINC IONS DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1999-06-29 US claimed
US-5902826-A WATER SOLUBLE DIAMINE-PLATINUM (IV) COMPLEX; SIDE EFFECT REDUCTION, WATER SOLUBLE, TREATMENT OF MALIGNANT TUMORS SS PHARMACEUTICAL CO., LTD. (JP) 1999-05-11 US claimed
EP-0896057-A2 D-aminoacylase DAICEL CHEMICAL INDUSTRIES, Ltd. (JP) 1999-02-10 EP claimed
EP-0864578-A2 Platinum (IV) complex and pharmaceutical composition comprising the same SS PHARMACEUTICAL CO., LTD. (JP) 1998-09-16 EP claimed
EP-0723586-A1 ENZYME AND ITS USE IN PREPARING (S)-PIPECOLIC ACID Chiroscience Limited (GB) 1996-07-31 EP claimed
EP-0451760-B1 Nitrato alkanoic acid derivatives and method for their production SANOL ARZNEI SCHWARZ GMBH (DE) 1995-09-13 EP claimed
WO-1995010604-A1 ENZYME AND ITS USE IN PREPARING (S)-PIPECOLIC ACID CHIROSCIENCE LIMITED (GB) 1995-04-20 WO claimed
US-5284872-A Nitrato alkanoic acid derivatives, methods for their production, pharmaceutical compositions containing the derivatives and medicinal uses thereof SCHWARZ PHARMA AG (DE) 1994-02-08 US claimed
US-4405638-A ANTITUSSIVE AGENTS; ANTIINFLAMMATORY AGENTS; RESPIRATORY SYSTEM DISORDERS SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A (IT) 1983-09-20 US claimed